Evaluation of Covid 19 Anxiety in Endometriosis Patients

Official Title

Endometriosis Patients Covid 19 Anxiety

Brief Summary

It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Status

Completed

Conditions

Endometriosis

COVID19

Eligibility Criteria

Inclusion Criteria:

- endometriosis patients

- no psychiatric illness

- no antidepressant use

Exclusion Criteria:

- women who had not endometriosis

- no extra health conditions

- women younger than 18 and older than 45

Eligibility Gender

Female

Eligibility Age

Minimum: 18 Years ~ Maximum: 45 Years

Countries

Turkey

Locations

Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey

NCT Number

NCT04337346

MeSH Terms

COVID-19

Endometriosis

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Kanuni Sultan Suleyman Training and Research Hospital

Evaluation of Covid 19 Anxiety in Endometriosis Patients

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA